FLT3-ITD Targeted Therapy in Fit AML Patients
Clinical trial NCT07425808 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07425808
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2028-10-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.